Risk factors for the development of gastric mucosal lesions in rheumatoid arthritis patients receiving long-term nonsteroidal anti-inflammatory drug therapy and the efficacy of famotidine obtained from the FORCE study

Modern Rheumatology

Volumn 19, Issue 6, 2009, Pages 629-636

  Kobata, Yasunori ^a   Yajima, Hiroshi ^a   Yamao, Junichi ^a   Tanaka, Yasuhito ^a   Fukui, Hiroshi ^a   Takakura, Yoshinori ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Famotidine; Mucosal lesion; NSAID; Rheumatoid arthritis; Steroid

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETODOLAC; FAMOTIDINE; LOXOPROFEN; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; REBAMIPIDE; STEROID;

ADULT; ANAMNESIS; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; HUMAN; LIFESTYLE; LONG TERM CARE; MALE; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; STOMACH MUCOSA LESION; STOMACH ULCER;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; ARTHRITIS, RHEUMATOID; FAMOTIDINE; FEMALE; GASTRIC MUCOSA; GASTROSCOPY; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STOMACH DISEASES; TREATMENT OUTCOME;

EID: 73349121627     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-009-0202-0     Document Type: Article

References (32)

1. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines 2002 Guidelines for the management of rheumatoid arthritis: 2002 Update Arthritis Rheum 46 2 328 346 10.1002/art.10148 (Pubitemid 34136570)
2. DB Jack 1997 One hundred years of aspirin Lancet 350 9075 437 439 10.1016/S0140-6736(97)07087-6 1:STN:280:DyaK2svgs1ajtQ%3D%3D 9259670 (Pubitemid 27331247)
3. JR Vane 1971 Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs Nat New Biol 231 25 232 235 1:CAS:528: DyaE3MXltVyjur4%3D 5284360
4. AH Douthwaite 1938 Gastroscopic observation of the effect of aspirin and certain other substances on the stomach Lancet 2 1222 1225 10.1016/S0140- 6736(00)78970-7
5. Y Shiokawa T Nobenaga T Saitoh S Asagi A Ogawa 1991 Epidemiological study on upper digestive injuries by non-steroidal anti-inflammatory drugs (in Japanese) Off J Jpn Rheum Assoc 31 96 111 1:STN:280:DyaK3MzhtlClsA%3D%3D
6. CP Armstrong AL Blower 1987 Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration Gut 28 527 532 10.1136/gut.28.5.527 1:STN:280:DyaL2s3kvVahsw%3D%3D 3596334
7. G Singh DR Ramey D Morfeld H Shi HT Hatoum JF Fries 1996 Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study Arch Intern Med 156 1530 1536 10.1001/archinte.156.14.1530 1:CAS:528:DyaK28XkvFyrtL8%3D 8687261 (Pubitemid 26244437)
8. Y Shiokawa T Nobenaga T Saitoh S Asagi A Ogawa 1991 Epidemiological study on upper digestive injuries by non-steroidal anti-inflammatory drugs (in Japanese) J Jpn Rheum Assoc 31 1 96 111 1:STN:280:DyaK3MzhtlClsA%3D%3D
9. J Yamao E Kikuchi M Matsumoto M Nakayama T Ann H Kojima, et al. 2006 Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE-famotidine or rebamipide in comparison by endoscopy) J Gastroenterol 41 1178 1185 10.1007/s00535-006-1952-5 1:CAS:528:DC%2BD2sXhsV2is7w%3D 17287897 (Pubitemid 46487208)
10. H Yajima J Yamao H Fukui Y Takakura 2007 Up-to-date information on gastric mucosal lesions from long-term NSAID therapy in orthopedic outpatients: a study using logistic regression analysis J Orthop Sci 12 4 341 346 10.1007/s00776-007-1139-9 1:CAS:528:DC%2BD2sXot1ynt7Y%3D 17657553 (Pubitemid 47174851)
11. Y Naito T Yoshikawa S Iinuma N Yagi K Matsuyama Y Boku, et al. 1998 Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study Dig Dis Sci 43 83 89
12. FL Lanza GL Royer RS Nelson TT Chen CE Seckman MF Rack 1981 A comparative endoscopic evaluation of the damaging effects of nonsteroidal anti-inflammatory agents on the gastric and duodenal mucosa Am J Gastroenterol 75 17 21 1:STN:280:DyaL3M3gsVentg%3D%3D 7234826
13. Japan Rheumatism Association; Treatment Manual for Rheumatoid Arthritis (Revised Version of Diagnostic Manual and EBM-based Treatment Guidelines) (in Japanese). Japan Rheumatism Foundation Information Center. 2004.
14. MM Wolfe DR Lichtenstein G Singh 1999 Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs N Engl J Med 340 1888 1899 10.1056/NEJM199906173402407 1:CAS:528:DyaK1MXktFKrtbs%3D 10369853 (Pubitemid 29272670)
15. JM Scheiman 2006 Unmet needs in non-steroidal anti-inflammatory drug-induced upper gastrointestinal diseases Drugs 66 suppl 1 15 21 10.2165/00003495-200666001-00004 1:CAS:528:DC%2BD28XltlKjtb8%3D 16869344
16. C Sakamoto K Sugano S Ota N Sakaki S Takahashi Y Yoshida, et al. 2006 Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan Eur J Clinic Pharmacol 62 9 765 772 10.1007/s00228-006-0171-6 1:CAS:528:DC%2BD28XotlChtrc%3D (Pubitemid 44289508)
17. LA Garcia Rodriguez S Hernandez-Diaz 2004 Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs Am J Epidemiol 159 1 23 31 10.1093/aje/kwh005 14693656 (Pubitemid 38049418)
18. DJ Sandweiss 1954 Effects of adrenocorticotropic hormone (ACTH) and of cortisone on peptic ulcer. I. Clinical review Gastroenterology 27 5 604 616 1:CAS:528:DyaG28Xls1Sh 13210598
19. HO Conn BL Blitzer 1976 Nonassociation of adrenocorticosteroid therapy and peptic ulcer N Eng J Med 294 9 473 479 1:STN:280:DyaE287gtVOiug%3D%3D
20. HO Conn T Poynard 1994 Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy J Int Med 236 619 632 10.1111/j.1365-2796.1994.tb00855.x 1:CAS:528:DyaK2MXjsVCmtLY%3D
21. J Messer D Reitman HS Sacks H Smith Jr TC Chalmers 1983 Association of adrenocorticosteroid therapy and peptic-ulcer disease N Eng J Med 309 21 24 1:STN:280:DyaL3s3hvFWmsw%3D%3D
22. GL Nielsen HT Sørensen L Mellemkjoer WJ Blot JK McLaughlin U Tage-Jensen, et al. 2001 Risk of hospitalization resulting from upper gastrointestinal bleeding among patients taking corticosteroids: a register-based cohort study Am J Med 111 7 541 545 10.1016/S0002-9343(01)00941-X 1:CAS:528:DC%2BD3MXot1Omu74%3D 11705430 (Pubitemid 33052352)
23. T Funatsu K Chono T Hirata Y Keto A Kimoto M Sasamata 2007 Mucosal acid causes gastric mucosal microcirculatory disturbance in nonsteroidal anti-inflammatory drug-treated rats Eur J Pharm. 554 53 59 10.1016/j.ejphar. 2006.10.023 1:CAS:528:DC%2BD28Xht1KksLrI (Pubitemid 44820047)
24. A Robert 1976 Antisecretory, antiulcer, cytoprotective and diarrheogenic properties of prostaglandins Adv Prostaglandin Thromboxane Res 2 507 520 1:CAS:528:DyaE28XhsVGjtbY%3D 983858
25. AS Taha N Hudson CJ Hawkey AJ Swannell PN Trye J Cottrell, et al. 1996 Famotidine for the prevention of gastric and duodenal ulcers caused by non-steroidal antiinflammatory drugs N Engl J Med 334 1435 1439 10.1056/NEJM199605303342204 1:CAS:528:DyaK28XktF2kurk%3D 8618582 (Pubitemid 26157439)
26. CJ Hawkey JA Karrasch L Szczepanski DG Walker A Barkun AJ Swannell, et al. 1998 Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group N Engl J Med 338 11 727 734 10.1056/NEJM199803123381105 1:CAS:528:DyaK1cXitFars7w%3D 9494149 (Pubitemid 28115091)
27. CS Wu SH Wang PC Chen VCC Wu 1998 Does famotidine have similar efficacy to misoprostol in the treatment of non-steroidal anti-inflammatory drug-induced gastropathy? Int J Clin Pract 52 7 472 474 1:CAS:528:DyaK1cXnslCjurc%3D 10622088
28. Research team for the development of guidelines for evidence-based gastric ulcer diagnosis, Guideline for Clinical Practice of Gastric Ulcer Based on EBM, 2nd ed (in Japanese). Jiho. 2007.
29. K Haruma T Kamada H Kawaguchi S Okamoto M Yoshihara K Sumii, et al. 2000 Effect of age and Helicobacter pylori infection on gastric acid secretion J Gastroenterol Hepatol 15 277 283 10.1046/j.1440-1746.2000.02131.x 1:STN:280:DC%2BD3c3isFSqug%3D%3D 10764028 (Pubitemid 30190741)
30. EM El-Omar ID Penman JES Ardill RS Chittajallu C Howie KEL Mccoll 1995 Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease Gastroenterology 109 681 691 10.1016/0016-5085(95) 90374-7 1:CAS:528:DyaK2MXos1Grtbk%3D 7657096
31. M Feldman CT Richardson SK Lam IM Samloff 1988 Comparison of gastric acid secretion rates and serum pepsinogen I and II concentrations in occidental and oriental duodenal ulcer patients Gastroenterology 95 630 635 1:STN:280:DyaL1c3osVWrtQ%3D%3D 3396811 (Pubitemid 18207422)
32. KT Toljamo SE Niemelä TJ Karttunen AL Karvonen JK Lehtola 2006 Clinical significance and outcome of gastric mucosal erosions: a long-term follow-up study Dig Dis Sci 51 3 543 547 10.1007/s10620-006-3168-1 1:STN:280:DC%2BD283gslGhuw%3D%3D 16614965